A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma

H.M. Lokhorst, B. van der Holt, S. Zweegman, E. Vellenga, S. Croockewit, M.H. van Oers, P.V. Borne, P. Wijermans, R. Schaafsma, O. de Weerdt, S. Wittebol, M. Delforge, H. Berenschot, G.M. Bos, K.S.G. Jie, H. Sinnige, M. van Marwijk-Kooy, P. Joosten, M.C. Minnema, R. van AmmerlaanP. Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1113-1120
JournalBlood
Volume115
Issue number6
DOIs
Publication statusPublished - 2010

Cite this